ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0587

Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic

Alfredo Aguirre1, Laura Trupin1, Sarah Patterson2, Kimberly DeQuattro2, Patricia Katz3, Cristina Lanata2, Stephanie Rush1, Lindsey Criswell4, Maria Dall'Era5 and Jinoos Yazdany1, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3University of California, San Francisco, Novato, CA, 4Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, University of California San Francisco, San Francisco, CA, 5Division of Rheumatology, University of California, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Access to care, COVID-19, Health Services Research, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Saturday, November 7, 2020

Session Title: Health Services Research Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The pandemic of coronavirus disease 19 (COVID-19) has led to widespread disruptions across the spectrum of healthcare. We sought to investigate barriers to medical care, including access to ambulatory rheumatology appointments and routine medications such as antimalarials among patients with systemic lupus erythematosus (SLE) in the San Francisco Bay Area using a diverse, population-based cohort.

Methods: Subjects with SLE in the longitudinal California Lupus Epidemiology Study (CLUES) were administered a structured telephone interview during the COVID-19 pandemic. Participants were asked about SLE disease activity, COVID-19 exposures and infection, demographic factors and patient-reported outcomes. We collected data on access to ambulatory rheumatology appointments. Participants were also asked about difficulties in obtaining timely antimalarial refills since March 2020, encompassing partially filled, delayed or denied refills. Using a multivariable logistic regression model, we investigated demographic (age, female sex, nonwhite race) and disease-related factors (Systemic Lupus Activity Questionnaire, or SLAQ) associated with barriers to timely antimalarial refills.

Results: 202 CLUES cohort members participated in this interview. The mean age was 50 (±13 SD), 91% were female, and 64% reported a nonwhite race/ethnicity. 89 of 99 (90%) participants who tried to access ambulatory rheumatologic care were able to obtain an appointment; 79% of this care was delivered via telephone or video visits. Of the 111 participants who attempted to refill their antimalarial since March 2020, 39 (35%) reported partially filled, delayed or denied refills. Barriers to timely antimalarial refills were not associated with age, female sex, nonwhite race or SLAQ score.

Conclusion: These data suggest that in the San Francisco Bay Area, there were minimal disruptions in access to rheumatologic care for people with SLE, which parallels the high rate of virtual care provided during the first months of the pandemic. However, participants with SLE did report considerable difficulties in obtaining antimalarial refills. This highlights the importance of ensuring an adequate supply and appropriate stewardship of a critical medication for patients with chronic diseases during the COVID-19 pandemic.


Disclosure: A. Aguirre, None; L. Trupin, None; S. Patterson, None; K. DeQuattro, None; P. Katz, None; C. Lanata, None; S. Rush, None; L. Criswell, None; M. Dall'Era, Janssen, 5, AstraZeneca, 5; J. Yazdany, Eli Lilly, 1, Astra Zeneca, 1.

To cite this abstract in AMA style:

Aguirre A, Trupin L, Patterson S, DeQuattro K, Katz P, Lanata C, Rush S, Criswell L, Dall'Era M, Yazdany J. Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/barriers-to-rheumatologic-care-and-antimalarial-refills-among-a-cohort-of-patients-with-systemic-lupus-erythematosus-during-the-covid-19-pandemic/. Accessed April 16, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/barriers-to-rheumatologic-care-and-antimalarial-refills-among-a-cohort-of-patients-with-systemic-lupus-erythematosus-during-the-covid-19-pandemic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.